26 / 100
272
Ces Urol 2016; 20(4): 259–274
PŘEHLEDOVÝ ČLÁNEK
8. Groen J, Pannek J, Castro Diaz D, et al.
Summary of European Association of Urology (EAU) Guidelines
on Neuro-Urology. European urology 2016; 69(2): 324–333.
9. Wheeler JS, Jr, Siroky MB, Pavlakis AJ, Goldstein I, Krane RJ.
The changing neurourologic pattern of
multiple sclerosis. The Journal of urology 1983; 130(6): 1123–1126.
10. de Seze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B.
The neurogenic bladder in multiple
sclerosis: review of the literature and proposal of management guidelines. Multiple sclerosis (Houndmills,
Basingstoke, England) 2007; 13(7): 915–928.
11. Amarenco G, de Seze M, Ruffion A, Sheikh Ismael S.
Clinical and urodynamic evaluations of urinary
disorders in multiple sclerosis. Annals of physical and rehabilitation medicine 2014; 57(5): 277–287.
12. Manack A, Motsko SP, Haag-Molkenteller C, et al.
Epidemiology and healthcare utilization of neu‑
rogenic bladder patients in a US claims database. Neurourology and urodynamics 2011; 30(3): 395–401.
13. Groen J, Pannek J, Castro Diaz D.
Summary of European Association of Urology (EAU) Guidelines on
Neuro-Urology. Eur Urol. 2016; 69(2): 324–333.
14. Madersbacher H.
The various types of neurogenic bladder dysfunction: an update of current thera‑
peutic concepts. Paraplegia 1990; 28(4): 217–229.
15. Zámečník L, Novák K, Hanuš T.
Pacient s roztroušenou sklerózou v ordinaci praktického urologa. Urol.
praxi 2001; 2(1): 58–62.
16. Fletcher SG, Dillon BE, Gilchrist AS, et al.
Renal deterioration in multiple sclerosis patients with neu‑
rovesical dysfunction. Multiple sclerosis (Houndmills, Basingstoke, England) 2013; 19(9): 1169–1174.
17. Krhut J, Hradilek P, Zapletalova O.
Analysis of the upper urinary tract function in multiple sclerosis
patients. Acta neurologica Scandinavica 2008; 118(2): 115–119.
18. Krhut J, Hradílek P, Mainer K, Zapletalová O.
Nové schéma v diagnostice a terapii dysfunkcí dolních
močových cest u pacientů s roztroušenou sklerózou. Urol. praxi 2005; 6(5): 209–212.
19. Del Popolo G, Panariello G, Del Corso F, De Scisciolo G, Lombardi G.
Diagnosis and therapy for neu‑
rogenic bladder dysfunctions in multiple sclerosis patients. Neurological sciences: official journal of the
Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2008; 29 Suppl 4: S352–355.
20. Colli E, Artibani W, Goka J, Parazzini F, Wein AJ.
Are urodynamic tests useful tools for the initial
conservative management of non-neurogenic urinary incontinence? A review of the literature. European
urology 2003; 43(1): 63–69.
21. Panicker JN, Fowler CJ, Kessler TM.
Lower urinary tract dysfunction in the neurological patient: clinical
assessment and management. The Lancet Neurology 2015; 14(7): 720–732.
22. Dillon BE, Lemack GE.
Urodynamics in the evaluation of the patient with multiple sclerosis: when
are they helpful and how do we use them? The Urologic clinics of North America 2014; 41(3): 439–444, ix.
23. Fowler CJ, Panicker JN, Drake M, et al.
A UK consensus on the management of the bladder in multiple
sclerosis. Postgraduate medical journal 2009; 85(1008): 552–559.
24. Zámečník L.
Mikční a sexuální poruchy. In: Havrdová E, editor. Roztroušená skleróza. Praha: Mladá
Fronta; 2013. 125–131.
25. Urodynamics.
In: Urinary Incontinence in Neurological Disease, Management of Lower Urinary Tract
Dysfunction in Neurological Disease. NICE Clinical Guidelines, No. 148. London: Royal College of Physicians
(UK); 2012. 53–63.
26. Lucio AC, Campos RM, Perissinotto MC, et al.
Pelvic floor muscle training in the treatment of lower
urinary tract dysfunction in women with multiple sclerosis. Neurourology and urodynamics 2010; 29(8):
1410–1413.
27. De Ridder D, Vermeulen C, Ketelaer P, Van Poppel H, Baert L.
Pelvic floor rehabilitation in multiple
sclerosis. Acta neurologica Belgica 1999; 99(1): 61–64.